NCT02781922View on ClinicalTrials.gov

Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)

PHASE3RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Hypoplastic Left Heart SyndromeSingle Ventricle
Interventions
GENETIC

Autologous cardiac stem cells (JRM-001)

3x 10\^5 cells/kg, single treatment

Trial Locations (4)

Unknown

RECRUITING

Kanagawa Children's Medical Center, Kanagawa

RECRUITING

Okayama University Hospital, Okayama

RECRUITING

Saitama Prefectural Children's Medical Center, Saitama

RECRUITING

Shizuoka Children's Hospital, Shizuoka

Sponsors

Lead Sponsor

Metcela Inc.
All Listed Sponsors
lead

Metcela Inc.

INDUSTRY